Iron Workers District Council of New England Health and Welfare Fund v. Teva Pharmaceutical Industries Ltd. et al
Case Number:
1:23-cv-11131
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Berman Tabacco
- Glancy Prongay
- Hagens Berman
- Kirkland & Ellis
- Korein Tillery
- Lockridge Grindal
- Sperling & Slater
Companies
Sectors & Industries:
-
November 07, 2024
Teva Can't End Inhaler Antitrust Suit But Gets Claim Nixed
A Massachusetts federal court refused Teva Pharmaceutical Industries Ltd.'s attempt to end a case accusing it of orchestrating a decade-long scheme to delay generic competition for its QVAR asthma inhalers, but cut allegations that Teva paid Amneal Pharmaceuticals Inc. not to launch its version.
-
July 10, 2024
Buyers Say Teva Had Multipart Scheme To Delay Inhaler Rivals
Employee benefit funds accusing Teva of orchestrating a decadelong scheme to delay generic competition for its QVAR asthma inhalers told a Massachusetts federal court the drugmaker is trying to end the case by addressing merely one aspect of a multipart scheme.
-
May 08, 2024
Teva Must Face Bulk Of Asthma Inhaler Antitrust Suit
A Massachusetts federal judge largely refused Tuesday to toss antitrust claims accusing Teva of a decadelong anticompetitive scheme to delay generic competition for its blockbuster QVAR asthma inhalers, finding it plausible that Teva paid off a would-be rival and forcibly switched doctors and patients to a new product.
-
May 22, 2023
Teva Accused Of Asthma Inhaler Antitrust Scheme
Teva was hit with a suit on Monday in Massachusetts federal court that alleges the pharmaceutical giant ran a nearly decadelong anticompetitive scheme to delay generic competition for QVAR, its blockbuster line of brand-name asthma inhalers.